VOMIDOM Tablet

Anorexia, abdominal fullness, abdominal pain, distension of abdomen, heart burn, belching.

Cancer therapy, and nausea and vomiting associated with levodopa or bromocriptine therapy for parkinsonism.

Dosage and Administration

Adults: 1-2 tablets 3 times daily before meals

Children: 1-2mg/kg daily in divided 3 doses of 3 times before meals.

Known hypersensitivity to domperidone or any of the excipients prolactin-releasing pituitary tumor (prolactinoma)

Co-administration with oral ketoconazole.

VOMIDOM should not be used whenever stimulation of gastrointestinal motility might be dangerous such as in the presence of gastrointestinal haemorrhage, mechanical obstruction, or perforation.

Immune system: Very rare: allergic reaction

Endocrine: Rare: increased prolactin levels

Nervous system: Very rare: extra pyramidal side effects

Gastrointestinal: Rare: gastrointestinal disorders, including very rate transient intestinal cramps

Skin and subcutaneous tissue: Very rare: urticaria

Reproductive system: Rare: amenorrhoea

Other: Rare: galactorrhoea, gynacomastia

Pregnancy

VOMIDOM should only be used during pregnancy when justified by the anticipated therapeutic benefit.

Use in hepatic impairment

Since domperidone is highly metabolized in the liver, VOMIDOM should be used with caution in patients with hepatic impairment.